SANA : Interim Report Q1 2024 - MarketScreener

INTERIM REPORT FOR SANIONA AB 556962-5345 January - March 2024


Published May 29, 2024


Advancing our epilepsy assets and driving innovation...

Related Keywords

Stockholm ,Sweden ,Mexico ,Copenhagen ,Køavn ,Denmark ,Boehringer Ingelheim Gmb ,Formue Nord ,Thomas Feldthus ,Productos Medix ,Boehringer Ingelheim ,Boehringer Ingelheim Gmbh ,Astronautx Limited ,Nasdaq Stockholm Main ,Positive Allosteric Modulator ,Genetic Absence Epilepsy Rat ,Trigeminal Neuralgia ,Positron Emission Tomography ,